The global LFA-based Cardiac Marker market is projected to grow from US$ 3715.1 million in 2024 to US$ 4620 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.7% during the forecast period.

LFA-based Cardiac Marker Market

Market Analysis and Insights: Global LFA-based Cardiac Marker Market

The US & Canada market for LFA-based Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for LFA-based Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for LFA-based Cardiac Marker is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of LFA-based Cardiac Marker include Thermo Fisher, Bio-Rad Laboratories, Becton, Dickinson, Roche, Hologic, Abbott, Siemens, Danaher and Alere, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

LFA-based Cardiac Marker is widely used in various fields, such as Laboratory Testing and Point-of-care Testing, etc. Laboratory Testing provides greatest supports to the LFA-based Cardiac Marker industry development. In 2023, global % revenue of LFA-based Cardiac Marker went into Laboratory Testing filed and the proportion will reach to % in 2030.

Report Covers:

This report presents an overview of global market for LFA-based Cardiac Marker market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of LFA-based Cardiac Marker, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for LFA-based Cardiac Marker, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the LFA-based Cardiac Marker revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global LFA-based Cardiac Marker market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for LFA-based Cardiac Marker revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of LFA-based Cardiac Marker Market Report

Report Metric	Details
Report Name	LFA-based Cardiac Marker Market
Accounted market size in 2024	US$ 3715.1 in million
Forecasted market size in 2030	US$ 4620 million
CAGR	3.7
Base Year	2024
Forecasted years	2025 - 2030
Segment by Type	Troponin CK-MB Myoglobin Others
Segment by Application	Laboratory Testing Point-of-care Testing
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher, Bio-Rad Laboratories, Becton, Dickinson, Roche, Hologic, Abbott, Siemens, Danaher, Alere, BioMérieux, LSI, Clinical Diagnostics, Randox laboratories, Wondfo Biotech
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of LFA-based Cardiac Marker in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of LFA-based Cardiac Marker companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, LFA-based Cardiac Marker revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is LFA-based Cardiac Marker Market growing?

Ans: The LFA-based Cardiac Marker Market witnessing a CAGR of 3.7 during the forecast period 2025-2030.

What is the LFA-based Cardiac Marker Market size in 2030?

Ans: The LFA-based Cardiac Marker Market size in 2030 will be US$ 4620 million.

Who are the main players in the LFA-based Cardiac Marker Market report?

Ans: The main players in the LFA-based Cardiac Marker Market are Thermo Fisher, Bio-Rad Laboratories, Becton, Dickinson, Roche, Hologic, Abbott, Siemens, Danaher, Alere, BioMérieux, LSI, Clinical Diagnostics, Randox laboratories, Wondfo Biotech

What are the Application segmentation covered in the LFA-based Cardiac Marker Market report?

Ans: The Applications covered in the LFA-based Cardiac Marker Market report are Laboratory Testing, Point-of-care Testing

What are the Type segmentation covered in the LFA-based Cardiac Marker Market report?

Ans: The Types covered in the LFA-based Cardiac Marker Market report are Troponin, CK-MB, Myoglobin, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Troponin

1.2.3 CK-MB

1.2.4 Myoglobin

1.2.5 Others

1.3 Market by Application

1.3.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Laboratory Testing

1.3.3 Point-of-care Testing

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global LFA-based Cardiac Marker Market Perspective (2019-2030)

2.2 Global LFA-based Cardiac Marker Growth Trends by Region

2.2.1 LFA-based Cardiac Marker Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 LFA-based Cardiac Marker Historic Market Size by Region (2019-2024)

2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Region (2025-2030)

2.3 LFA-based Cardiac Marker Market Dynamics

2.3.1 LFA-based Cardiac Marker Industry Trends

2.3.2 LFA-based Cardiac Marker Market Drivers

2.3.3 LFA-based Cardiac Marker Market Challenges

2.3.4 LFA-based Cardiac Marker Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue LFA-based Cardiac Marker by Players

3.1.1 Global LFA-based Cardiac Marker Revenue by Players (2019-2024)

3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2019-2024)

3.2 Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of LFA-based Cardiac Marker, Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global LFA-based Cardiac Marker Market Concentration Ratio

3.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2023

3.5 Global Key Players of LFA-based Cardiac Marker Head office and Area Served

3.6 Global Key Players of LFA-based Cardiac Marker, Product and Application

3.7 Global Key Players of LFA-based Cardiac Marker, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 LFA-based Cardiac Marker Breakdown Data by Type

4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2019-2024)

4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2025-2030)

5 LFA-based Cardiac Marker Breakdown Data by Application

5.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2019-2024)

5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America LFA-based Cardiac Marker Market Size (2019-2030)

6.2 North America LFA-based Cardiac Marker Market Size by Type

6.2.1 North America LFA-based Cardiac Marker Market Size by Type (2019-2024)

6.2.2 North America LFA-based Cardiac Marker Market Size by Type (2025-2030)

6.2.3 North America LFA-based Cardiac Marker Market Share by Type (2019-2030)

6.3 North America LFA-based Cardiac Marker Market Size by Application

6.3.1 North America LFA-based Cardiac Marker Market Size by Application (2019-2024)

6.3.2 North America LFA-based Cardiac Marker Market Size by Application (2025-2030)

6.3.3 North America LFA-based Cardiac Marker Market Share by Application (2019-2030)

6.4 North America LFA-based Cardiac Marker Market Size by Country

6.4.1 North America LFA-based Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America LFA-based Cardiac Marker Market Size by Country (2019-2024)

6.4.3 North America LFA-based Cardiac Marker Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe LFA-based Cardiac Marker Market Size (2019-2030)

7.2 Europe LFA-based Cardiac Marker Market Size by Type

7.2.1 Europe LFA-based Cardiac Marker Market Size by Type (2019-2024)

7.2.2 Europe LFA-based Cardiac Marker Market Size by Type (2025-2030)

7.2.3 Europe LFA-based Cardiac Marker Market Share by Type (2019-2030)

7.3 Europe LFA-based Cardiac Marker Market Size by Application

7.3.1 Europe LFA-based Cardiac Marker Market Size by Application (2019-2024)

7.3.2 Europe LFA-based Cardiac Marker Market Size by Application (2025-2030)

7.3.3 Europe LFA-based Cardiac Marker Market Share by Application (2019-2030)

7.4 Europe LFA-based Cardiac Marker Market Size by Country

7.4.1 Europe LFA-based Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe LFA-based Cardiac Marker Market Size by Country (2019-2024)

7.4.3 Europe LFA-based Cardiac Marker Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China LFA-based Cardiac Marker Market Size (2019-2030)

8.2 China LFA-based Cardiac Marker Market Size by Type

8.2.1 China LFA-based Cardiac Marker Market Size by Type (2019-2024)

8.2.2 China LFA-based Cardiac Marker Market Size by Type (2025-2030)

8.2.3 China LFA-based Cardiac Marker Market Share by Type (2019-2030)

8.3 China LFA-based Cardiac Marker Market Size by Application

8.3.1 China LFA-based Cardiac Marker Market Size by Application (2019-2024)

8.3.2 China LFA-based Cardiac Marker Market Size by Application (2025-2030)

8.3.3 China LFA-based Cardiac Marker Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia LFA-based Cardiac Marker Market Size (2019-2030)

9.2 Asia LFA-based Cardiac Marker Market Size by Type

9.2.1 Asia LFA-based Cardiac Marker Market Size by Type (2019-2024)

9.2.2 Asia LFA-based Cardiac Marker Market Size by Type (2025-2030)

9.2.3 Asia LFA-based Cardiac Marker Market Share by Type (2019-2030)

9.3 Asia LFA-based Cardiac Marker Market Size by Application

9.3.1 Asia LFA-based Cardiac Marker Market Size by Application (2019-2024)

9.3.2 Asia LFA-based Cardiac Marker Market Size by Application (2025-2030)

9.3.3 Asia LFA-based Cardiac Marker Market Share by Application (2019-2030)

9.4 Asia LFA-based Cardiac Marker Market Size by Region

9.4.1 Asia LFA-based Cardiac Marker Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia LFA-based Cardiac Marker Market Size by Region (2019-2024)

9.4.3 Asia LFA-based Cardiac Marker Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Type

10.2.1 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Application

10.3.1 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Country

10.4.1 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Thermo Fisher

11.1.1 Thermo Fisher Company Details

11.1.2 Thermo Fisher Business Overview

11.1.3 Thermo Fisher LFA-based Cardiac Marker Introduction

11.1.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.1.5 Thermo Fisher Recent Developments

11.2 Bio-Rad Laboratories

11.2.1 Bio-Rad Laboratories Company Details

11.2.2 Bio-Rad Laboratories Business Overview

11.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction

11.2.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.2.5 Bio-Rad Laboratories Recent Developments

11.3 Becton, Dickinson

11.3.1 Becton, Dickinson Company Details

11.3.2 Becton, Dickinson Business Overview

11.3.3 Becton, Dickinson LFA-based Cardiac Marker Introduction

11.3.4 Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.3.5 Becton, Dickinson Recent Developments

11.4 Roche

11.4.1 Roche Company Details

11.4.2 Roche Business Overview

11.4.3 Roche LFA-based Cardiac Marker Introduction

11.4.4 Roche Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.4.5 Roche Recent Developments

11.5 Hologic

11.5.1 Hologic Company Details

11.5.2 Hologic Business Overview

11.5.3 Hologic LFA-based Cardiac Marker Introduction

11.5.4 Hologic Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.5.5 Hologic Recent Developments

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Abbott Business Overview

11.6.3 Abbott LFA-based Cardiac Marker Introduction

11.6.4 Abbott Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.6.5 Abbott Recent Developments

11.7 Siemens

11.7.1 Siemens Company Details

11.7.2 Siemens Business Overview

11.7.3 Siemens LFA-based Cardiac Marker Introduction

11.7.4 Siemens Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.7.5 Siemens Recent Developments

11.8 Danaher

11.8.1 Danaher Company Details

11.8.2 Danaher Business Overview

11.8.3 Danaher LFA-based Cardiac Marker Introduction

11.8.4 Danaher Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.8.5 Danaher Recent Developments

11.9 Alere

11.9.1 Alere Company Details

11.9.2 Alere Business Overview

11.9.3 Alere LFA-based Cardiac Marker Introduction

11.9.4 Alere Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.9.5 Alere Recent Developments

11.10 BioMérieux

11.10.1 BioMérieux Company Details

11.10.2 BioMérieux Business Overview

11.10.3 BioMérieux LFA-based Cardiac Marker Introduction

11.10.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.10.5 BioMérieux Recent Developments

11.11 LSI

11.11.1 LSI Company Details

11.11.2 LSI Business Overview

11.11.3 LSI LFA-based Cardiac Marker Introduction

11.11.4 LSI Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.11.5 LSI Recent Developments

11.12 Clinical Diagnostics

11.12.1 Clinical Diagnostics Company Details

11.12.2 Clinical Diagnostics Business Overview

11.12.3 Clinical Diagnostics LFA-based Cardiac Marker Introduction

11.12.4 Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.12.5 Clinical Diagnostics Recent Developments

11.13 Randox laboratories

11.13.1 Randox laboratories Company Details

11.13.2 Randox laboratories Business Overview

11.13.3 Randox laboratories LFA-based Cardiac Marker Introduction

11.13.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.13.5 Randox laboratories Recent Developments

11.14 Wondfo Biotech

11.14.1 Wondfo Biotech Company Details

11.14.2 Wondfo Biotech Business Overview

11.14.3 Wondfo Biotech LFA-based Cardiac Marker Introduction

11.14.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2019-2024)

11.14.5 Wondfo Biotech Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Troponin

Table 3. Key Players of CK-MB

Table 4. Key Players of Myoglobin

Table 5. Key Players of Others

Table 6. Global LFA-based Cardiac Marker Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 7. Global LFA-based Cardiac Marker Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global LFA-based Cardiac Marker Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global LFA-based Cardiac Marker Market Share by Region (2019-2024)

Table 10. Global LFA-based Cardiac Marker Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global LFA-based Cardiac Marker Market Share by Region (2025-2030)

Table 12. LFA-based Cardiac Marker Market Trends

Table 13. LFA-based Cardiac Marker Market Drivers

Table 14. LFA-based Cardiac Marker Market Challenges

Table 15. LFA-based Cardiac Marker Market Restraints

Table 16. Global LFA-based Cardiac Marker Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global LFA-based Cardiac Marker Revenue Share by Players (2019-2024)

Table 18. Global Top LFA-based Cardiac Marker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2023)

Table 19. Global LFA-based Cardiac Marker Industry Ranking 2022 VS 2023 VS 2024

Table 20. Global 5 Largest Players Market Share by LFA-based Cardiac Marker Revenue (CR5 and HHI) & (2019-2024)

Table 21. Global Key Players of LFA-based Cardiac Marker, Headquarters and Area Served

Table 22. Global Key Players of LFA-based Cardiac Marker, Product and Application

Table 23. Global Key Players of LFA-based Cardiac Marker, Product and Application

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global LFA-based Cardiac Marker Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global LFA-based Cardiac Marker Revenue Market Share by Type (2019-2024)

Table 27. Global LFA-based Cardiac Marker Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global LFA-based Cardiac Marker Revenue Market Share by Type (2025-2030)

Table 29. Global LFA-based Cardiac Marker Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global LFA-based Cardiac Marker Revenue Share by Application (2019-2024)

Table 31. Global LFA-based Cardiac Marker Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global LFA-based Cardiac Marker Revenue Share by Application (2025-2030)

Table 33. North America LFA-based Cardiac Marker Market Size by Type (2019-2024) & (US$ Million)

Table 34. North America LFA-based Cardiac Marker Market Size by Type (2025-2030) & (US$ Million)

Table 35. North America LFA-based Cardiac Marker Market Size by Application (2019-2024) & (US$ Million)

Table 36. North America LFA-based Cardiac Marker Market Size by Application (2025-2030) & (US$ Million)

Table 37. North America LFA-based Cardiac Marker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. North America LFA-based Cardiac Marker Market Size by Country (2019-2024) & (US$ Million)

Table 39. North America LFA-based Cardiac Marker Market Size by Country (2025-2030) & (US$ Million)

Table 40. Europe LFA-based Cardiac Marker Market Size by Type (2019-2024) & (US$ Million)

Table 41. Europe LFA-based Cardiac Marker Market Size by Type (2025-2030) & (US$ Million)

Table 42. Europe LFA-based Cardiac Marker Market Size by Application (2019-2024) & (US$ Million)

Table 43. Europe LFA-based Cardiac Marker Market Size by Application (2025-2030) & (US$ Million)

Table 44. Europe LFA-based Cardiac Marker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Europe LFA-based Cardiac Marker Market Size by Country (2019-2024) & (US$ Million)

Table 46. Europe LFA-based Cardiac Marker Market Size by Country (2025-2030) & (US$ Million)

Table 47. China LFA-based Cardiac Marker Market Size by Type (2019-2024) & (US$ Million)

Table 48. China LFA-based Cardiac Marker Market Size by Type (2025-2030) & (US$ Million)

Table 49. China LFA-based Cardiac Marker Market Size by Application (2019-2024) & (US$ Million)

Table 50. China LFA-based Cardiac Marker Market Size by Application (2025-2030) & (US$ Million)

Table 51. Asia LFA-based Cardiac Marker Market Size by Type (2019-2024) & (US$ Million)

Table 52. Asia LFA-based Cardiac Marker Market Size by Type (2025-2030) & (US$ Million)

Table 53. Asia LFA-based Cardiac Marker Market Size by Application (2019-2024) & (US$ Million)

Table 54. Asia LFA-based Cardiac Marker Market Size by Application (2025-2030) & (US$ Million)

Table 55. Asia LFA-based Cardiac Marker Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 56. Asia LFA-based Cardiac Marker Market Size by Region (2019-2024) & (US$ Million)

Table 57. Asia LFA-based Cardiac Marker Market Size by Region (2025-2030) & (US$ Million)

Table 58. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Type (2019-2024) & (US$ Million)

Table 59. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Type (2025-2030) & (US$ Million)

Table 60. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Application (2019-2024) & (US$ Million)

Table 61. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Application (2025-2030) & (US$ Million)

Table 62. Middle East, Africa, and Latin America LFA-based Cardiac Marker Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 63. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Country (2019-2024) & (US$ Million)

Table 64. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size by Country (2025-2030) & (US$ Million)

Table 65. Thermo Fisher Company Details

Table 66. Thermo Fisher Business Overview

Table 67. Thermo Fisher LFA-based Cardiac Marker Product

Table 68. Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 69. Thermo Fisher Recent Developments

Table 70. Bio-Rad Laboratories Company Details

Table 71. Bio-Rad Laboratories Business Overview

Table 72. Bio-Rad Laboratories LFA-based Cardiac Marker Product

Table 73. Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 74. Bio-Rad Laboratories Recent Developments

Table 75. Becton, Dickinson Company Details

Table 76. Becton, Dickinson Business Overview

Table 77. Becton, Dickinson LFA-based Cardiac Marker Product

Table 78. Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 79. Becton, Dickinson Recent Developments

Table 80. Roche Company Details

Table 81. Roche Business Overview

Table 82. Roche LFA-based Cardiac Marker Product

Table 83. Roche Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 84. Roche Recent Developments

Table 85. Hologic Company Details

Table 86. Hologic Business Overview

Table 87. Hologic LFA-based Cardiac Marker Product

Table 88. Hologic Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 89. Hologic Recent Developments

Table 90. Abbott Company Details

Table 91. Abbott Business Overview

Table 92. Abbott LFA-based Cardiac Marker Product

Table 93. Abbott Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 94. Abbott Recent Developments

Table 95. Siemens Company Details

Table 96. Siemens Business Overview

Table 97. Siemens LFA-based Cardiac Marker Product

Table 98. Siemens Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 99. Siemens Recent Developments

Table 100. Danaher Company Details

Table 101. Danaher Business Overview

Table 102. Danaher LFA-based Cardiac Marker Product

Table 103. Danaher Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 104. Danaher Recent Developments

Table 105. Alere Company Details

Table 106. Alere Business Overview

Table 107. Alere LFA-based Cardiac Marker Product

Table 108. Alere Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 109. Alere Recent Developments

Table 110. BioMérieux Company Details

Table 111. BioMérieux Business Overview

Table 112. BioMérieux LFA-based Cardiac Marker Product

Table 113. BioMérieux Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 114. BioMérieux Recent Developments

Table 115. LSI Company Details

Table 116. LSI Business Overview

Table 117. LSI LFA-based Cardiac Marker Product

Table 118. LSI Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 119. LSI Recent Developments

Table 120. Clinical Diagnostics Company Details

Table 121. Clinical Diagnostics Business Overview

Table 122. Clinical Diagnostics LFA-based Cardiac Marker Product

Table 123. Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 124. Clinical Diagnostics Recent Developments

Table 125. Randox laboratories Company Details

Table 126. Randox laboratories Business Overview

Table 127. Randox laboratories LFA-based Cardiac Marker Product

Table 128. Randox laboratories Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 129. Randox laboratories Recent Developments

Table 130. Wondfo Biotech Company Details

Table 131. Wondfo Biotech Business Overview

Table 132. Wondfo Biotech LFA-based Cardiac Marker Product

Table 133. Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2019-2024) & (US$ Million)

Table 134. Wondfo Biotech Recent Developments

Table 135. Research Programs/Design for This Report

Table 136. Key Data Information from Secondary Sources

Table 137. Key Data Information from Primary Sources

List of Figures

Figure 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global LFA-based Cardiac Marker Market Share by Type: 2023 VS 2030

Figure 3. Troponin Features

Figure 4. CK-MB Features

Figure 5. Myoglobin Features

Figure 6. Others Features

Figure 7. Global LFA-based Cardiac Marker Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global LFA-based Cardiac Marker Market Share by Application: 2023 VS 2030

Figure 9. Laboratory Testing Case Studies

Figure 10. Point-of-care Testing Case Studies

Figure 11. LFA-based Cardiac Marker Report Years Considered

Figure 12. Global LFA-based Cardiac Marker Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global LFA-based Cardiac Marker Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global LFA-based Cardiac Marker Market Share by Region: 2023 VS 2030

Figure 15. Global LFA-based Cardiac Marker Market Share by Players in 2023

Figure 16. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in LFA-based Cardiac Marker as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by LFA-based Cardiac Marker Revenue in 2023

Figure 18. North America LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America LFA-based Cardiac Marker Market Share by Type (2019-2030)

Figure 20. North America LFA-based Cardiac Marker Market Share by Application (2019-2030)

Figure 21. North America LFA-based Cardiac Marker Market Share by Country (2019-2030)

Figure 22. United States LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe LFA-based Cardiac Marker Market Size YoY (2019-2030) & (US$ Million)

Figure 25. Europe LFA-based Cardiac Marker Market Share by Type (2019-2030)

Figure 26. Europe LFA-based Cardiac Marker Market Share by Application (2019-2030)

Figure 27. Europe LFA-based Cardiac Marker Market Share by Country (2019-2030)

Figure 28. Germany LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. France LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. U.K. LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Italy LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Russia LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Nordic Countries LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. China LFA-based Cardiac Marker Market Size YoY (2019-2030) & (US$ Million)

Figure 35. China LFA-based Cardiac Marker Market Share by Type (2019-2030)

Figure 36. China LFA-based Cardiac Marker Market Share by Application (2019-2030)

Figure 37. Asia LFA-based Cardiac Marker Market Size YoY (2019-2030) & (US$ Million)

Figure 38. Asia LFA-based Cardiac Marker Market Share by Type (2019-2030)

Figure 39. Asia LFA-based Cardiac Marker Market Share by Application (2019-2030)

Figure 40. Asia LFA-based Cardiac Marker Market Share by Region (2019-2030)

Figure 41. Japan LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. South Korea LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. China Taiwan LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Southeast Asia LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. India LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Australia LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Size YoY (2019-2030) & (US$ Million)

Figure 48. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Share by Type (2019-2030)

Figure 49. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Share by Application (2019-2030)

Figure 50. Middle East, Africa, and Latin America LFA-based Cardiac Marker Market Share by Country (2019-2030)

Figure 51. Brazil LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 52. Mexico LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 53. Turkey LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Saudi Arabia LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Israel LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. GCC Countries LFA-based Cardiac Marker Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 58. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 59. Becton, Dickinson Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 60. Roche Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 61. Hologic Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 62. Abbott Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 63. Siemens Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 64. Danaher Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 65. Alere Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 66. BioMérieux Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 67. LSI Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 68. Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 69. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 70. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Marker Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions